175 related articles for article (PubMed ID: 29105189)
41. Renal allograft tolerance in DLA-identical and haploidentical dogs after nonmyeloablative conditioning and transient immunosuppression with cyclosporine and mycophenolate mofetil.
Niemeyer GP; Welch JA; Tillson M; Brawner W; Rynders P; Goodman S; Dufresne M; Dennis J; Lothrop CD
Transplant Proc; 2005 Dec; 37(10):4579-86. PubMed ID: 16387175
[TBL] [Abstract][Full Text] [Related]
42. Role of the cytokine profiles produced by invariant natural killer T cells in the initial phase of cyclophosphamide-induced tolerance.
Onzuka T; Tomita Y; Shimizu I; Okano S; Yamada H; Yoshikai Y; Tominaga R
Transplantation; 2008 Nov; 86(9):1301-10. PubMed ID: 19005413
[TBL] [Abstract][Full Text] [Related]
43. Tolerance-inducing immunosuppressive strategies in clinical transplantation: an overview.
Golshayan D; Pascual M
Drugs; 2008; 68(15):2113-30. PubMed ID: 18840003
[TBL] [Abstract][Full Text] [Related]
44. [Transplant tolerance through mixed chimerism].
Zuber J
Nephrol Ther; 2017 Apr; 13 Suppl 1():S127-S130. PubMed ID: 28577733
[TBL] [Abstract][Full Text] [Related]
45. A substantial level of donor hematopoietic chimerism is required to protect donor-specific islet grafts in diabetic NOD mice.
Guo Z; Wu T; Sozen H; Pan Y; Heuss N; Kalscheuer H; Sutherland DE; Blazar BR; Hering BJ
Transplantation; 2003 Apr; 75(7):909-15. PubMed ID: 12698073
[TBL] [Abstract][Full Text] [Related]
46. Chimerism and tolerance induction in kidney transplantation.
Traitanon O; Gallon L
Nephron; 2015; 129(1):34-8. PubMed ID: 25531026
[TBL] [Abstract][Full Text] [Related]
47. Bringing transplantation tolerance into the clinic: lessons from the ITN and RISET for the Establishment of Tolerance consortia.
Turka LA; Wood K; Bluestone JA
Curr Opin Organ Transplant; 2010 Aug; 15(4):441-8. PubMed ID: 20631613
[TBL] [Abstract][Full Text] [Related]
48. Tolerance induction: hematopoietic chimerism.
Kawai T; Sachs DH
Curr Opin Organ Transplant; 2013 Aug; 18(4):402-7. PubMed ID: 23838644
[TBL] [Abstract][Full Text] [Related]
49. Recent progress in tolerance induction through mixed chimerism.
Pree I; Pilat N; Wekerle T
Int Arch Allergy Immunol; 2007; 144(3):254-66. PubMed ID: 17596699
[TBL] [Abstract][Full Text] [Related]
50. Chimerism-based Tolerance Induction in Clinical Transplantation: Its Foundations and Mechanisms.
Mengrelis K; Muckenhuber M; Wekerle T
Transplantation; 2023 Dec; 107(12):2473-2485. PubMed ID: 37046378
[TBL] [Abstract][Full Text] [Related]
51. T-regulatory cells in chronic rejection versus stable grafts.
Al-Wedaie F; Farid E; Tabbara K; El-Agroudy AE; Al-Ghareeb SM
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():170-6. PubMed ID: 25894149
[TBL] [Abstract][Full Text] [Related]
52. Transplantation of hematopoietic stem cells for induction of unresponsiveness to organ allografts.
Prigozhina T; Slavin S
Springer Semin Immunopathol; 2004 Nov; 26(1-2):169-85. PubMed ID: 15368079
[TBL] [Abstract][Full Text] [Related]
53. Kidney Versus Islet Allograft Survival After Induction of Mixed Chimerism With Combined Donor Bone Marrow Transplantation.
Oura T; Ko DS; Boskovic S; O'Neil JJ; Chipashvili V; Koulmanda M; Hotta K; Kawai K; Nadazdin O; Smith RN; Cosimi AB; Kawai T
Cell Transplant; 2016; 25(7):1331-41. PubMed ID: 26337731
[TBL] [Abstract][Full Text] [Related]
54. Cyclophosphamide-induced chimera-type tolerance to allografts: an overview of drug-induced immunological tolerance.
Mayumi H; Tokunaga K
Fukuoka Igaku Zasshi; 1990 Jan; 81(1):20-39. PubMed ID: 2182492
[TBL] [Abstract][Full Text] [Related]
55. Application of xenogeneic stem cells for induction of transplantation tolerance: present state and future directions.
Yang YG
Springer Semin Immunopathol; 2004 Nov; 26(1-2):187-200. PubMed ID: 15378269
[TBL] [Abstract][Full Text] [Related]
56. Immunosuppressive drugs for kidney transplantation.
Halloran PF
N Engl J Med; 2004 Dec; 351(26):2715-29. PubMed ID: 15616206
[No Abstract] [Full Text] [Related]
57. Relationship between chimerism and tolerance in a kidney transplantation model.
Fuchimoto Y; Yamada K; Shimizu A; Yasumoto A; Sawada T; Huang CH; Sachs DH
J Immunol; 1999 May; 162(10):5704-11. PubMed ID: 10229802
[TBL] [Abstract][Full Text] [Related]
58. Transplantation tolerance. A complex scenario awaiting clinical applicability.
Sayegh MH; Perico N; Remuzzi G
Contrib Nephrol; 2005; 146():95-104. PubMed ID: 15567924
[TBL] [Abstract][Full Text] [Related]
59. Mechanisms of Tolerance Induction by Hematopoietic Chimerism: The Immune Perspective.
Yolcu ES; Shirwan H; Askenasy N
Stem Cells Transl Med; 2017 Mar; 6(3):700-712. PubMed ID: 28186688
[TBL] [Abstract][Full Text] [Related]
60. Effects of Antirejection Drugs on Innate Immune Cells After Kidney Transplantation.
Zaza G; Leventhal J; Signorini L; Gambaro G; Cravedi P
Front Immunol; 2019; 10():2978. PubMed ID: 31921213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
